Publication | Closed Access

A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders

Substance AbusePsychiatryHealth PolicyAddictionPsychopharmacologyAddiction MedicineMedicaid PatientsSocial SciencesMood DisordersChronic PsychiatricBenzodiazepine UseDrug TreatmentMedicinePsychopathology